The board of directors of Fitchburg-based Arrhythmia Research Technology declared a semi-annual cash dividend of $0.06 per share.
The dividend will be paid to stockholders on record as of Feb. 15 and will be payable on March 1.
James E. Rouse, president and CEO of Arrhythmia, said in a statement that “strong operating cash flows in 2010” enabled the dividend issue.
Â
